0001209191-20-020659.txt : 20200323 0001209191-20-020659.hdr.sgml : 20200323 20200323164431 ACCESSION NUMBER: 0001209191-20-020659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200319 FILED AS OF DATE: 20200323 DATE AS OF CHANGE: 20200323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bright Rex CENTRAL INDEX KEY: 0001327501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 20735377 MAIL ADDRESS: STREET 1: 5641 LAKE VISTA DRIVE CITY: BONSALL STATE: CA ZIP: 92003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Menlo Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-486-1416 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-19 0 0001566044 Menlo Therapeutics Inc. MNLO 0001327501 Bright Rex 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 1 0 0 0 Stock Option 2.67 2020-03-19 4 A 0 45000 0.00 A 2030-03-19 Common Stock 45000 45000 D The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. /s/ Mutya Harsch as attorney-in-fact for Rex Bright 2020-03-23